A field study by researchers at Ludwig-Maximilians-University Munich followed climbers ascending to 4554 metres in the Italian Alps and measured CGRP, a neuropeptide central to migraine, in tear fluid. Those who developed moderate-to-severe headache showed a marked rise in CGRP, while mildly affected climbers did not, suggesting a shared mechanism with migraine rather than oxygen levels alone.